By utilizing extracellular vesicle proteomics analysis, a recent study discovered elevated levels of CTSB in the cerebrospinal fluid and plasma extracellular vesicles of AD patients with amyloid progression [18]. The gene discussed is CTSB; the disease is Alzheimer disease.